179 related articles for article (PubMed ID: 25120702)
1. Isolated duodenal myeloid sarcoma associated with the
Huang B; You P; Zhu P; DU Z; Wu B; Xu X; Chen Z
Oncol Lett; 2014 Sep; 8(3):1261-1264. PubMed ID: 25120702
[TBL] [Abstract][Full Text] [Related]
2. Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.
Zhang W; Wang H; Zhang P; Li H; Ma X; Liu H
Braz J Med Biol Res; 2021; 54(12):e11605. PubMed ID: 34730684
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of p210
Wang YY; Ding WJ; Jiang F; Chen ZX; Cen JN; Qi XF; Liang JY; Liu DD; Pan JL; Chen SN
Oncol Lett; 2017 Nov; 14(5):5171-5178. PubMed ID: 29151902
[TBL] [Abstract][Full Text] [Related]
4. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
[TBL] [Abstract][Full Text] [Related]
5. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
[TBL] [Abstract][Full Text] [Related]
6. Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics.
Costello R; Sainty D; Lecine P; Cusenier A; Mozziconacci MJ; Arnoulet C; Maraninchi D; Gastaut JA; Imbert J; Lafage-Pochitaloff M; Gabert J
Leukemia; 1997 May; 11(5):644-50. PubMed ID: 9180286
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion.
Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
[TBL] [Abstract][Full Text] [Related]
8. Granulocytic sarcoma of the small bowel, greater omentum and peritoneum associated with a CBFβ/MYH11 fusion and inv(16) (p13q22): a case report.
Alvarez P; Navascués CA; Ordieres C; Pipa M; Vega IF; Granero P; Alvarez JA; Rodríguez M
Int Arch Med; 2011 Jan; 4(1):3. PubMed ID: 21255400
[TBL] [Abstract][Full Text] [Related]
9. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
[TBL] [Abstract][Full Text] [Related]
10. Granulocytic sarcoma of the small intestine with CBFbeta/MYH11 fusion gene: report of an aleukaemic case and review of the literature.
Xavier SG; Fagundes EM; Hassan R; Bacchi C; Conchon M; Tabak DG; Spector N; Zalcberg IR
Leuk Res; 2003 Nov; 27(11):1063-6. PubMed ID: 12859999
[TBL] [Abstract][Full Text] [Related]
11. Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression.
Xiaosu Z; Leqing C; Yazhen Q; Yu W; Xiaohui Z; Lanping X; Xiaojun H; Yingjun C
Ann Hematol; 2019 Jan; 98(1):73-81. PubMed ID: 30159599
[TBL] [Abstract][Full Text] [Related]
12. Type J CBFbeta/MYH11 transcript in the M4Eo subtype of acute myeloid leukemia.
Trnková Z; Peková S; Bedrlíková R; Záková D; Zemanová Z; Polák J; Michalová K; Cermák J; Schwarz J
Hematology; 2003 Apr; 8(2):115-7. PubMed ID: 12745661
[TBL] [Abstract][Full Text] [Related]
13. HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.
Richter LE; Wang Y; Becker ME; Coburn RA; Williams JT; Amador C; Hyde RK
Mol Cancer Res; 2019 Jun; 17(6):1241-1252. PubMed ID: 30814129
[TBL] [Abstract][Full Text] [Related]
14. [Molecular Genetic Characteristics of Acute Myeloid Leukemia Patients with
Jiang Y; Chao HY; Lu XZ; Wu P; Sun XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1661-1667. PubMed ID: 36476886
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.
Kanagal-Shamanna R; Zhao W; Vadhan-Raj S; Nguyen MH; Fernandez MH; Medeiros LJ; Bueso-Ramos CE
Int J Environ Res Public Health; 2012 Aug; 9(8):2788-800. PubMed ID: 23066397
[TBL] [Abstract][Full Text] [Related]
16. [The Prognostic Factors for AML Children with CBFβ/MYH11 Positive].
Yan M; Song FX; Lu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):369-373. PubMed ID: 33812401
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Mrózek K; Prior TW; Edwards C; Marcucci G; Carroll AJ; Snyder PJ; Koduru PR; Theil KS; Pettenati MJ; Archer KJ; Caligiuri MA; Vardiman JW; Kolitz JE; Larson RA; Bloomfield CD
J Clin Oncol; 2001 May; 19(9):2482-92. PubMed ID: 11331327
[TBL] [Abstract][Full Text] [Related]
18. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):. PubMed ID: 35400360
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):367-372. PubMed ID: 35395965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
